Stay updated on Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new entry Revision: v3.3.3 was added to the history, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-24T15:56:55.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    New revision entry v3.3.2 appears in Study Record Versions, and v3.2.0 is no longer listed. The updates reflect revision history and QC status details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:49:06.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The top government funding notice banner has been removed, and the study record content remains unaffected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-18T07:30:25.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Routine version updates are shown in the record history and do not modify the core trial details; no new information affecting eligibility, interventions, or outcomes is introduced, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-27T21:11:35.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.
    Difference
    12%
    Check dated 2025-10-06T08:59:31.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    - The page now shows Revision: v3.1.0, replacing the previous v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-29T07:32:49.000Z thumbnail image

Stay in the know with updates to Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page.